8-K
filed June 1, 2026, 4:28 PM ET
ticker LESL
CIK 0001821806
regulatory
confidence high
sentiment positive
materiality 0.70
Leslie's regains Nasdaq compliance for minimum market value of publicly held shares
Leslie's, Inc.
- Received Nasdaq deficiency on Feb 11, 2026 for failing to maintain $15M MVPHS per Rule 5450(b)(3)(C).
- Regained compliance by meeting $15M MVPHS threshold from May 14 to May 28, 2026.
- Nasdaq confirmed compliance on May 29, 2026; matter is now closed.
Featured in Daily 8-K Digest
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001193125-26-251517
- form_type
- 8-K
- ticker
- LESL
- cik
- 0001821806
- company_name
- Leslie's, Inc.
- filed_at
- 2026-06-01T20:28:42+00:00
- discovered_at
- 2026-06-01T20:30:00.264028+00:00
- generated_at
- 2026-06-01T20:37:36.230345+00:00
- sec_items
- ["8.01"]
- event_type
- regulatory
- sentiment
- positive
- materiality_score
- 0.7
- calibrated_materiality_score
- 0.7
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001193125-26-251517
- json_url
- https://secwatch.observer/filing/0001193125-26-251517.json
- markdown_url
- https://secwatch.observer/filing/0001193125-26-251517.md
- text_url
- https://secwatch.observer/filing/0001193125-26-251517.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1821806/000119312526251517/0001193125-26-251517-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1821806/000119312526251517/lesl-20260529.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
VYGR
FDA clears IND for VY1706, Voyager's tau-silencing gene therapy for Alzheimer's
Voyager Therapeutics, Inc.
June 1, 2026, 8:00 AM ET
regulatory
Items 8.01
same SEC item: 8.01
same event type: regulatory
similar materiality
Filing page
SEC filing
EXFY
Expensify regains Nasdaq minimum bid price compliance
Expensify, Inc.
May 29, 2026, 5:15 PM ET
regulatory
Items 8.01
same SEC item: 8.01
same event type: regulatory
similar materiality
Filing page
SEC filing
SLXN
Silexion Therapeutics completes 1-for-10 reverse share split; warrants adjusted
Silexion Therapeutics Corp
May 29, 2026, 7:00 AM ET
regulatory
Items 3.03, 5.03, 8.01, 9.01
same SEC item: 8.01
same event type: regulatory
similar materiality
Filing page
SEC filing
RR
Richtech Robotics receives Nasdaq delisting notice for late Q1 10-Q filing
RICHTECH ROBOTICS INC.
May 28, 2026, 4:49 PM ET
regulatory
Items 3.01, 8.01, 9.01
same SEC item: 8.01
same event type: regulatory
similar materiality
Filing page
SEC filing
MNKD
FDA releases MannKind from Afrezza malignancy study; sBLA for children PDUFA May 29
MANNKIND CORP
May 28, 2026, 8:37 AM ET
regulatory
Items 8.01
same SEC item: 8.01
same event type: regulatory
similar materiality
Filing page
SEC filing
SNAL
Snail receives Nasdaq extension to Sept 22, 2026 to regain listing compliance
Snail, Inc.
May 27, 2026, 4:25 PM ET
regulatory
Items 8.01
same SEC item: 8.01
same event type: regulatory
similar materiality
Filing page
SEC filing
JAGX
Jaguar Health regains Nasdaq Bid Price compliance; monitoring until May 2027
Jaguar Health, Inc.
May 27, 2026, 9:10 AM ET
regulatory
Items 7.01, 8.01, 9.01
same SEC item: 8.01
same event type: regulatory
similar materiality
Filing page
SEC filing
FCUV
Focus Universal regains Nasdaq equity compliance after Series B conversion and $4M warrant offering
FOCUS UNIVERSAL INC.
May 26, 2026, 3:19 PM ET
regulatory
Items 8.01
same SEC item: 8.01
same event type: regulatory
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.